文献速递心力衰竭与心肌病

青春期前非综合征型肥厚型心肌病的临床特征与自然病史

Clinical Features and Natural History of Preadolescent Nonsyndromic Hypertrophic Cardiomyopathy.
PubMed 文献 · J Am Coll Cardiol · 2022-01-01

国际儿童肥厚型心肌病联盟回顾639例12岁前诊断的非综合征型HCM患儿,并与568例12-16岁诊断者比较。两组症状负担与心脏表型相当,长期死亡率与致命性心律失常事件发生率无差异,但12岁前诊断者不良事件发生年龄更小,接受心肌切除术比例更高而一级预防ICD植入比例更低。

要点

  • 12岁前诊断的HCM患儿不良事件发生年龄更早,但长期死亡率与心律失常事件率与晚诊断者无差异。
  • 12岁前诊断者心肌切除术比例更高(10.5% vs 7.2%),一级预防ICD植入比例更低(18.9% vs 30.1%)。
  • 基线时53.6%有HCM家族史,20.9%有心衰症状,27.2%存在左室流出道梗阻。

核心结论

  • 早发型儿童HCM的症状负担和心脏表型与儿童期较晚诊断者相当,长期结局无年龄差异,但12岁前诊断者不良事件发生年龄更小。

研究设计与样本

  • 国际儿童肥厚型心肌病联盟(International Paediatric Hypertrophic Cardiomyopathy Consortium)数据,纳入639例12岁前诊断的非综合征型HCM患儿,与568例12-16岁诊断者比较。

主要发现

  • 基线时339例(53.6%)有HCM家族史,132例(20.9%)有心衰症状,250例(39.2%)使用心脏药物。
  • 中位最大左室壁厚度z评分为8.7(IQR:5.3-14.4),145例(27.2%)存在左室流出道梗阻。
  • 中位随访5.6年(IQR:2.3-10.0年)期间,42例(6.6%)死亡,21例(3.3%)接受心脏移植,69例(10.8%)发生致命性心律失常事件。
  • 与12岁后诊断者相比,12岁前诊断者心肌切除术比例更高(10.5% vs 7.2%;P=0.045),一级预防ICD植入比例更低(18.9% vs 30.1%;P=0.041)。
  • 死亡或致命性心律失常事件发生率无差异,但事件发生在更小年龄。

临床怎么用

  • 对12岁前诊断的非综合征型HCM患儿应认识到其不良事件可能更早出现,需加强早期监测与风险评估。
  • 该群体一级预防ICD植入比例较低而心肌切除术比例较高,临床决策需结合年龄与个体风险综合考量。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Up to one-half of childhood sarcomeric hypertrophic cardiomyopathy (HCM) presents before the age of 12 years, but this patient group has not been systematically characterized. OBJECTIVES: The aim of this study was to describe the clinical presentation and natural history of patients presenting with nonsyndromic HCM before the age of 12 years. METHODS: Data from the International Paediatric Hypertrophic Cardiomyopathy Consortium on 639 children diagnosed with HCM younger than 12 years were collected and compared with those from 568 children diagnosed between 12 and 16 years. RESULTS: At baseline, 339 patients (53.6%) had family histories of HCM, 132 (20.9%) had heart failure symptoms, and 250 (39.2%) were prescribed cardiac medications. The median maximal left ventricular wall thickness z-score was 8.7 (IQR: 5.3-14.4), and 145 patients (27.2%) had left ventricular outflow tract obstruction. Over a median follow-up period of 5.6 years (IQR: 2.3-10.0 years), 42 patients (6.6%) died, 21 (3.3%) underwent cardiac transplantation, and 69 (10.8%) had life-threatening arrhythmic events. Compared with those presenting after 12 years, a higher proportion of younger patients underwent myectomy (10.5% vs 7.2%; P = 0.045), but fewer received primary prevention implantable cardioverter-defibrillators (18.9% vs 30.1%; P = 0.041). The incidence of mortality or life-threatening arrhythmic events did not differ, but events occurred at a younger age. CONCLUSIONS: Early-onset childhood HCM is associated with a comparable symptom burden and cardiac phenotype as in patients presenting later in childhood. Long-term outcomes including mortality did not differ by age of presentation, but patients presenting at younger than 12 years experienced adverse events at younger ages.

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Norrish G, Cleary A, Field E, et al. Clinical Features and Natural History of Preadolescent Nonsyndromic Hypertrophic Cardiomyopathy. J Am Coll Cardiol. 2022. PMID: 35589160. doi:10.1016/j.jacc.2022.03.347

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。